PRESCRIPTION DRUG AFFORDABILITY BOARD

Van T. Mitchell, Chair (chosen by Senate President & House Speaker)

Appointed by Governor: Joseph F. Levy, Ph.D.

Appointed by Senate President: Renee C. Bovelle, M.D.

Appointed by House Speaker: Eberechukwu Onukwugha, Ph.D.

Appointed by Attorney General: Gerard F. Anderson

Andrew York, J.D., Pharm.D., Executive Director

Maryland Prescription Drug Affordability Board
16900 Science Drive, Suite 112-114, Bowie MD, 20715
(410) 804-0251; fax: (443) 213-0187
e-mail: andrew.york@maryland.gov
web: https://pdab.maryland.gov/index.html

Annual Report to Senate Finance Committee & House Health & Government Operations Committee due Dec. 31, beginning 2021 (Chapter 692, Acts of 2019; Code Health - General Article, secs. 21-2C-01 through 21-2C-15).
EXECUTIVE DIRECTOR
Andrew York, J.D., Pharm.D., Executive Director (410) 804-0251; fax: (443) 213-0187
e-mail: andrew.york@maryland.gov

In July 2019, the Prescription Drug Affordability Board was authorized by the General Assembly (Chapter 692, Acts of 2019).

In conjunction with the Prescription Drug Affordability Stakeholder Council, the Board identifies circumstances under which the cost of a prescription drug product may create or has created affordability challenges for the State health care system and patients; and establishes criteria that the Board will use to set an upper payment limit for a prescription drug product after considering certain factors (Code Health-General Article, sec. 21-2C-01 through 21-2C-15).

The Board consists of five members and five alternate members appointed to five-year terms (Code Health-General Article, sec. 21-2C-03).

Maryland Constitutional Offices & Agencies
Maryland Departments
Maryland Independent Agencies
Maryland Executive Commissions, Committees, Task Forces, & Advisory Boards
Maryland Universities & Colleges
Maryland Counties
Maryland Municipalities
Maryland at a Glance

Maryland Manual On-Line

© Copyright Maryland State Archives